Pancreatic Cancer Research

ResearcherWestern UniversityActive in the last 2 years

Juan Glinka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4373-965X; OpenAlex author ID A5049133758. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer. First author DOI 10.14701/ahbps.23-107↗
  2. Early pancreatic cancer in IgG4-related pancreatic mass: A case report. Co-author DOI 10.4240/wjgs.v11.i12.443↗
  3. Use of radiotherapy in patients with palliative double bypass for locally advanced pancreatic adenocarcinoma. Co-author DOI 10.3857/roj.2018.00206↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel Adam Breadner · 1 shared paper, 2024 · strength 0.22
  2. Evelyn V. Waugh · 1 shared paper, 2024 · strength 0.22
  3. Ephraim Shin-Tian Tang · 1 shared paper, 2024 · strength 0.22
  4. Anton I. Skaro · 1 shared paper, 2024 · strength 0.22
  5. Ken A. Leslie · 1 shared paper, 2024 · strength 0.22
  6. Martín de Santibañes · 2 shared papers, 2018–2019 · strength 0.18
  7. Eduardo de Santibáñes · 2 shared papers, 2018–2019 · strength 0.18
  8. Oscar Mazza · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.